NYU Epilepsy Self-Management Study

Recruiting now · Not applicable

Conditions studied: Epilepsy

In brief

The investigators will conduct two-arm randomized controlled trials (RCTs) comparing effects of UPLIFT vs. enhanced usual care and PACES vs. enhanced usual care, respectively, on quality of life, depressive symptoms and seizures over 12 months in NYU patients with epilepsy.

Key facts

Study ID

NCT07087821

Run by

NYU Langone Health

People needed

108

Starts

2025-09-16

Expected to finish

2027-09-29

Last updated by the study team

2026-05-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (≥18 years)
• English-speaking (UPLIFT and PACES) or Spanish-speaking (UPLIFT only).
• Diagnosed with epilepsy for at least one year
• Able to understand the informed consent and provide consent
• Elevated depressive symptoms - Patient Health Questionnaire-9 (PHQ-9) score ≥10; applies to UPLIFT only

You may not qualify if…

• Severe depressive symptoms (score of ≥20 on PHQ-9)
• Active suicidal ideation (score of ≥1 on PHQ-9 item #9 or otherwise reported during screening)
• Active psychotic disorder (psychiatric diagnosis and/or antipsychotic medications in the electronic health records (EHR)
• Significant cognitive impairment (indicated in the EHR or evident during screening)

Where it is running

• NYU Langone Health - NYU Langone Hospital-Brooklyn — Brooklyn, New York, United States (enrolling)
• NYU Langone Health - NYU Comprehensive Epilepsy Center — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.